Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Kolon Life Science Inc.
DescriptionCell-mediated gene therapy based on bone morphogenetic protein 2 (BMP2) expressing mesenchymal stem cell (MSC)
Molecular Target Bone morphogenetic protein 2 (BMP2)
Mechanism of ActionCell therapy
Therapeutic ModalityCell therapy: Stem cell
Latest Stage of DevelopmentPreclinical
Standard IndicationBone repair
Indication DetailsTreat bone fractures; Treat non-union bone fractures
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today